Quick Answer
Lucid Diagnostics Inc. reported Shares Outstanding of 131.10 million shares for fiscal year 2025.
Lucid Diagnostics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 131.10M | +107.9% |
| 2024 | 63.07M | +49.0% |
| 2023 | 42.33M | +4.5% |
| 2022 | 40.52M | +16.0% |
| 2021 | 34.92M | +147.4% |
| 2020 | 14.11M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 130.92M | +153.7% | +28.6% |
| June 30, 2025 | 101.83M | +106.4% | +20.7% |
| March 31, 2025 | 84.37M | +80.5% | +33.8% |
| December 31, 2024 | 63.07M | +49.0% | +22.2% |
| September 30, 2024 | 51.60M | +21.9% | +4.6% |
| June 30, 2024 | 49.34M | +17.9% | +5.6% |
| March 31, 2024 | 46.75M | +12.0% | +10.4% |
| December 31, 2023 | 42.33M | +4.5% | +0.0% |
- Lucid Diagnostics Inc. showed an increase of +107.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Lucid Diagnostics Inc.’s shares outstanding has grown by 828.8% (from 14.11 million shares to 131.10 million shares).
- The most recent figure is from Lucid Diagnostics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: